SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies

Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA.
Nucleic Acids Research (Impact Factor: 8.81). 06/2009; 37(Web Server issue):W600-5. DOI: 10.1093/nar/gkp290
Source: PubMed

ABSTRACT We have developed a set of web-based SNP selection tools (freely available at where investigators can specify genes or linkage regions and select SNPs based on GWAS results, linkage disequilibrium (LD), and predicted functional characteristics of both coding and non-coding SNPs. The algorithm uses GWAS SNP P-value data and finds all SNPs in high LD with GWAS SNPs, so that selection is from a much larger set of SNPs than the GWAS itself. The program can also identify and choose tag SNPs for SNPs not in high LD with any GWAS SNP. We incorporate functional predictions of protein structure, gene regulation, splicing and miRNA binding, and consider whether the alternative alleles of a SNP are likely to have differential effects on function. Users can assign weights for different functional categories of SNPs to further tailor SNP selection. The program accounts for LD structure of different populations so that a GWAS study from one ethnic group can be used to choose SNPs for one or more other ethnic groups. Finally, we provide an example using prostate cancer and demonstrate that this algorithm can select a small panel of SNPs that include many of the recently validated prostate cancer SNPs.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: This study was conducted to investigate the association between TP53 Arg72Pro polymorphism (rs1042522) and risk of endometriosis. Studies were retrieved from Pubmed, Embase and HuGENet, and four models [dominant (AA+AG vs. GG), recessive (AA vs. AG+GG), co-dominant (AA vs. AG, AA vs. GG) and allele analysis (A vs. G), combined with odds ratios (OR) and 95% confidence intervals (CI)], were applied to evaluate this association. Fourteen eligible studies from eight countries were included. The pooled analysis identified a significant association between TP53 Arg72Pro polymorphism (rs1042522) and risk of endometriosis [dominant: OR 0.746, 95% CI 0.585-0.952, I(2)=59%; recessive: OR 0.650, 95% CI 0.510-0.829, I(2)=73%; co-dominant (GG vs. GC): OR 0.676, 95% CI 0.637-0.851, I(2)=67%; co-dominant (GG vs. CC): OR 0.564, 95% CI 0.395-0.806, I(2)=74%; allele analysis: OR 0.762, 95% CI 0.654-0.888, I(2)=71%]. In the subgroup analysis, the same positive associations were found among Asians. After removing studies that did not satisfy Hardy-Weinberg equilibrium, significant correlations were confirmed in both the pooled analysis and the Asian subgroup. Three bioinformatic methods (TagSNP calculations, functional prediction and linkage disequilibrium analysis) were used to determine the importance of TP53 Arg72Pro polymorphism (rs1042522), and suggested that this locus may be equally important regardless of ethnicity. In conclusion, TP53 Arg72Pro polymorphism (rs1042522) was positively associated with risk of endometriosis, particularly among Asians. However, its potential role in Caucasians should not be ignored. Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
    European journal of obstetrics, gynecology, and reproductive biology 04/2015; 189. DOI:10.1016/j.ejogrb.2015.03.026 · 1.63 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Schizophrenia (SZ) and bipolar disorder (BD) have substantial negative impact on the quality of human life. Both, microRNA (miRNA) expression profiling in SZ and BD postmortem brains [and genome-wide association studies (GWAS)] have implicated miRNAs in disease etiology. Here, we aim to determine whether significant GWAS signals observed in the Psychiatric Genetic Consortium (PGC) are enriched for miRNAs. A two-stage approach was used to determine whether association signals from PGC affect miRNAs: (i) statistical assessment of enrichment using a Simes test and sum of squares test (SST) and (ii) biological evidence that quantitative trait loci (eQTL) mapping to known miRNA genes affect their expression in an independent sample of 78 postmortem brains from the Stanley Medical Research Institute. A total of 2567 independent single nucleotide polymorphisms (SNPs) (R 2 > 0.8) were mapped locally, within 1 Mb, to all known miRNAs (miRBase v. 21). We show robust enrichment for SZ- and BD-related SNPs with miRNAs using Simes (SZ: p ≤ 0.0023, BD: p ≤ 0.038), which remained significant after adjusting for background inflation in SZ (empirical p = 0.018) and approached significance in BD (empirical p = 0.07). At a false discovery rate of 10%, we identified a total of 32 eQTLs to influence miRNA expression; 11 of these overlapped with BD. Our approach of integrating PGC findings with eQTL results can be used to generate specific hypotheses regarding the role of miRNAs in SZ and BD.
    Psychological Medicine 03/2015; DOI:10.1017/S0033291715000483 · 5.43 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Latrophilin 3 (LPHN3) is a brain-specific member of the G-protein coupled receptor family associated to both Attention-Deficit/Hyperactivity Disorder (ADHD) genetic susceptibility and methylphenidate pharmacogenetics.. Interactions of LPHN3 variants with variants harbored in the 11q chromosome improve the prediction of ADHD development and medication response. The aim of the present study was to evaluate the role LPHN3 variants in childhood ADHD susceptibility and treatment response in a naturalistic clinical cohort. The association between LPHN3 and ADHD was evaluated in 523 children and adolescents with ADHD and 132 controls. In the pharmacogenetics study, 172 children with ADHD were investigated. The primary outcome measure was the parent-rated Swanson, Nolan, and Pelham Scale - version IV applied at baseline, first and third months of treatment with methylphenidate. The results reported herein suggest the CGC haplotype derived from SNPs rs6813183, rs1355368, rs734644 as an ADHD risk haplotype (P = 0.02; OR = 1.46). Although non-significant after multiple testing correction, its interaction with the 11q chromosome SNP rs965560 slightly increases risk (nominal P = 0.03; OR = 1.55). Homozygous individuals for the CGC haplotype showed faster response to MPH treatment as a significant interaction effect between CGC haplotype and treatment over time was observed (P < 0.001). Homozygous individuals for the GT haplotype derived from SNPs rs6551665 and rs1947275 showed a significant interaction with treatment over time (nominal P = 0.04). Our findings replicate previous findings reporting that LPHN3 confers ADHD susceptibility, and moderates MPH treatment response in children and adolescents with ADHD. This article is protected by copyright. All rights reserved.
    Genes Brain and Behavior 05/2015; DOI:10.1111/gbb.12224 · 3.51 Impact Factor

Preview (2 Sources)

Available from